An area of PTC in ATCs has been shown to undergo dedifferentiation, and this process has been reported to be correlated with gaining an additional p53 mutation in BRAF-mutated PTCs [25, 26]. The gene discussed is BRAF; the disease is Ehlers-Danlos syndrome, musculocontractural type.